In this white paper, Bhausaheb Patil, Head of Business Operations, Decentralized Clinical Trials at IQVIA shares recently completed analysis comparing the tech-enabled model to traditional study models and how DCTs delivered time and cost efficiencies at virtually every point in the clinical research journey.
Read what 14 value measures analysts used to showcase the positive trends and impacts seen by using a combination of DCT technologies and in-home support to streamline trial operations.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
.svg){kind=icon}
